Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral response

Journal of Immunology

Volumn 187, Issue 7, 2011, Pages 3565-3577

  King, R Glenn ^a   Herrin, Brantley R ^a   Justement, Louis B ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; HEMATOPOIETIC SRC HOMOLOGY 2 CONTAINING ADAPTOR PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; GERMINAL CENTER; IMMUNITY, HUMORAL; LYMPHOPOIESIS; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80053463790     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101534     Document Type: Article

References (33)

1. Herrin, B. R., A. L. Groeger, and L. B. Justement. 2005. The adaptor protein HSH2 attenuates apoptosis in response to ligation of the B cell antigen receptor complex on the B lymphoma cell line, WEHI-231. J. Biol. Chem. 280: 3507-3515. (Pubitemid 40223816)
2. Herrin, B. R., and L. B. Justement. 2006. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J. Immunol. 176: 4163-4172. (Pubitemid 44264396)
3. Gauld, S. B., D. Blair, C. A. Moss, S. D. Reid, and M. M. Harnett. 2002. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells. J. Immunol. 168: 3855-3864. (Pubitemid 34298387)
4. Mineva, N. D., T. L. Rothstein, J. A. Meyers, A. Lerner, and G. E. Sonenshein. 2007. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J. Biol. Chem. 282: 17475-17485. (Pubitemid 47100319)
5. Schauer, S. L., R. E. Bellas, and G. E. Sonenshein. 1998. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J. Immunol. 160: 4398-4405. (Pubitemid 28217297)
6. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782. (Pubitemid 43905877)
7. Hagman, J., C. M. Rudin, D. Haasch, D. Chaplin, and U. Storb. 1990. A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B. Genes Dev. 4: 978-992.
8. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
9. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
10. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620. (Pubitemid 37311441)
11. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192: 1453-1466.
12. Thompson, J. S., P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. MacKay, S. A. Bixler, M. Zafari, Z. Y. Liu, et al. 2000. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192: 129-135. (Pubitemid 30470814)
13. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990-993. (Pubitemid 23080672)
14. Castigli, E., F. W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A. K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91: 12135-12139. (Pubitemid 24368619)
15. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180: 157-163. (Pubitemid 24181064)
16. Korthäuer, U., D. Graf, H. W. Mages, F. Brière, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539-541. (Pubitemid 23055615)
17. Reimold, A. M., N. N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E. M. Gravallese, D. Friend, M. J. Grusby, F. Alt, and L. H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307. (Pubitemid 32691837)
18. Schneider, P., H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel, S. Lens, T. G. Cachero, D. Finke, F. Beermann, and J. Tschopp. 2001. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194: 1691-1697. (Pubitemid 33126819)
19. Perchonock, C. E., M. C. Fernando, W. J. Quinn, III, C. T. Nguyen, J. Sun, M. J. Shapiro, and V. S. Shapiro. 2006. Negative regulation of interleukin-2 and p38 mitogen-activated protein kinase during T-cell activation by the adaptor ALX. Mol. Cell. Biol. 26: 6005-6015. (Pubitemid 44204520)
20. Shapiro, M. J., P. Powell, A. Ndubuizu, C. Nzerem, and V. S. Shapiro. 2004. The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP. J. Biol. Chem. 279: 40647-40652. (Pubitemid 39287658)
21. Pullen, S. S., H. G. Miller, D. S. Everdeen, T. T. Dang, J. J. Crute, and M. R. Kehry. 1998. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37: 11836-11845. (Pubitemid 28400055)
22. Gardam, S., F. Sierro, A. Basten, F. Mackay, and R. Brink. 2008. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28: 391-401.
23. Graham, J. P., C. R. Moore, and G. A. Bishop. 2009. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1. J. Immunol. 183: 2966-2973.
24. Morrison, M. D., W. Reiley, M. Zhang, and S. C. Sun. 2005. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. J. Biol. Chem. 280: 10018-10024. (Pubitemid 40395852)
25. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153: 4357-4366. (Pubitemid 24346830)
26. Qian, Y., J. Qin, G. Cui, M. Naramura, E. C. Snow, C. F. Ware, R. L. Fairchild, S. A. Omori, R. C. Rickert, M. Scott, et al. 2004. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21: 575-587. (Pubitemid 39370512)
27. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999. (Pubitemid 30243593)
28. Wu, Y., D. Bressette, J. A. Carrell, T. Kaufman, P. Feng, K. Taylor, Y. Gan, Y. H. Cho, A. D. Garcia, E. Gollatz, et al. 2000. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275: 35478-35485.
29. Xu, S., and K. P. Lam. 2001. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21: 4067-4074. (Pubitemid 32476467)
30. O'Connor, B. P., V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L. L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199: 91-98.
31. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2: 638-643. (Pubitemid 32677632)
32. Mantchev, G. T., C. S. Cortesão, M. Rebrovich, M. Cascalho, and R. J. Bram. 2007. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J. Immunol. 179: 2282-2288.
33. Castigli, E., S. Scott, F. Dedeoglu, P. Bryce, H. Jabara, A. K. Bhan, E. Mizoguchi, and R. S. Geha. 2004. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 101: 3903-3908. (Pubitemid 38381075)